AMWatch

Sunstone-selskab nærmere svensk hovedbørs

Det svenske biotekselskab Cantargia fortsætter bestræbelserne mod at blive noteret på den svenske hovedbørs Nasdaq Stockholm og lever nu op til forudsætninger for dette.

Photo: Nasdaq

Det børsnoterede svenske biotekselskab Cantargia sigter i 2018 mod at træde ind på den helt store børsscene i Stockholm, og den ambition er nu kommet et stridt nærmere.

Således meddeler selskabet, der er noteret på Nasdaq Firsth North, at det nu lever op til de skrappere krav til blandt andet information til aktionærer, regnskabsføring og selskabsledelse, der er en forudsætning for at blive noteret på hovedbørsen Nasdaq Stockholm.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

The ESG market is controlled by a few big investors

Finland's largest investor holds 62 percent of shares of multi-trillion ETFs offered by iShares and 64 percent of Xtrackers' equivalent offering. Having a few investors dominating ownership in this way is not good for the vehicles' liquidity and could be a big challenge facing the sector.

"We continue to see further growth in our Nordic book of business"

DECEMBER SERIES: What were the most important developments at some of the global asset managers present on the Nordic market in 2021, and what are their expectations for the coming year? AMWatch's December series is kicked off by Head of Nordics at State Street Global Advisors, Arnaud Bruyneel. 

Related articles

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch